Keywords: taisho, fiscal, sees, sales, drop, japan, reported
Taisho's fiscal year sees 2.4% sales drop
Article | 30 May 2005
Japan's Taisho has reported a year-on-year decline in consolidated earnings due to weak sales of over-the-counter and prescription drugs. Total ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
